Incyte expands in Scandinavia and plans to more than double its employees
With several scheduled launches, Incyte Biosciences is in a hurry to expand the organization's local departments. This is also the case in the Nordics, where the General Manager Erik Fromm expects to double the firm's employees.
BY ELIZABETH MØNSTED JOHANSEN, TRANSLATED BY NIELSINE NIELSEN
The US biotech firm Incyte is still in the process of setting up shop in Denmark and the Nordics, but it plans to grow in the coming years. The company is already growing in size both in and outside of the US, according to Incyte's General Manager Erik Fromm, who currently leads 12 employees across the Nordics.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
Novartis CEO: It’ll take more than vaccines to fight covid
For subscribers
IO Biotech CEO after US failure: "It doesn't worry me"
For subscribers
.jpg)
